SlideShare a Scribd company logo
1 of 14
Strategies for
assessment of global
disease burden
Dr. Nagula Praveen
 WHO was founded in 1948.
 GBD study – Global Burden of Diseases study (1997)
 Standardized approach to the epidemiological assessment of medical conditions
and risk factors.
 The main categories are
 1. communicable, maternal, neonatal, and nutritional diseases
 2. non- communicable diseases
 3. injuries
 Risk factors associated with these conditions under the main categories are
 A. Environmental risks
 B. Behavioural risks
 C. Metabolic risks
Dis Mod - MR
• Can be used to estimate age- , sex-, and country –
specific prevalence from heterogenous and often sparse
data sets.
• Burden associated with each condition is measured as
disability – adjusted life years (DALYs)
DALYs
• Combine information regarding premature death (years of
life lost, YLLs) as well as disability caused by the condition
(years lived with disability, YLDs)
• One DALY corresponds to one lost year of health and is
calculated as YLL plus YLD.
• YLDs- multiplying the estimated number of incident cases
by the average duration of the disease and a disability
weight factor (range 0-1 where 0 is total health and 1 is
total disability)
Epidemiology and global
burden of hypertension
Introduction
• In 2015, exposure to high systolic blood pressure (BP)
accounted for 10.7 million deaths (33.2% of deaths
attributed to all risk factors)
• Nearly 212 DALYs or 20.9 % of DALYs from all risk
factors.
• It is a leading cause of outpatient visits and a major cause
of hospitalization for stroke, chronic kidney disease, heart
failure and other CVDs.
• In adults, BP levels for defining hypertension are chosen
based on their relation to cardiovascular morbidity and
mortality.
• In children, the definition of hypertension is arbitrarily
based on the normal distribution of BP in healthy children
and not on BP partition values associated with any
cardiovascular morbidity and mortality.
Hypertension
• Chronic elevation of average systolic BP at 140mm Hg or
higher and/or diastolic BP at 90 mmHg or higher.
SBP DBP
Hypertension ≥ 140 mm Hg ≥ 90 mm Hg
High normal 130-139 mm Hg 85-89 mm Hg
normal 120 -129 mm Hg 80-89 mm Hg
ideal <120 mm Hg < 80 mm Hg
Hypertension
( not for ≥ 16 years)
SBP, DBP at 95 percentile for sex, age and height, when
measured on atleast three separate occasions
High normal BP >90 < 95 percentile
Grade I 95 -99 + 5 mm Hg
Grade II > 99 + 5 mm Hg
Primary, secondary and resistant
hypertension
• No specific cause can be identified on physical
examination and routine laboratory evaluation.
• Specific etiology of hypertension idenitified
• 5-10% in adults
• Children and adolescentes 85%
• Resistant hypertension – more than target range with
patient using three medications (including diuretic)
White coat hypertension
• Average BPs in the doctors office are routinely in the
hypertension range while home BP measurements or 24
hour ambulatory BP measurements show normotension.
• Masked hypertension or white coat normotension
• 23% for SBP , 24% for DBP
• 40% in some studies
• Selenta and colleagues – coined the term
WHO STEP wise approach to
surveillance
• Age standardized prevalence of hypertension was 33.2%.
• Prevalence is highest in Africa in the range of 30% for all adults
combined
• Lowest in America at 18%.
• Adverse intrauterine environment and low birth weight
contribute to high BP in children.
• 2.6% increase in risk of high SBP in overweight children
compared with non-overweight children.
• Sedentary lifestyle and physical inactivity were risk factors
• Boys more than girls affected.
• Three out of four adults – family history of hypertension
• Half of children – family history of hypertension
• Association is even greater when both parents have
hypertension.
•
• Risk of CVD doubles for each increment of 30 m mHg of
SBP or 10mm Hg DBP.
• 40-9 years – increment in BP is associated with two fold
difference in the stroke death rate, and ischaemic heart
disease and from other vascular causes.
• Lower BP does not confer protection against CVD
• >57% of all myocardial infarctions and nearly half of all
strokes occur in persons with BP in the normal range.
• Rapsomaniki et al
• 5.2 year median follow up
• Association with high systolic BP were strongest for
intracerebral hemorrhage, sub arachnoid hemorrhage and
stable angina
• Weakest for abdominal aortic aneurysm

More Related Content

What's hot

Review of current health service planning in Nepal from province to local level
Review of current health service planning in Nepal from province to local levelReview of current health service planning in Nepal from province to local level
Review of current health service planning in Nepal from province to local levelMohammad Aslam Shaiekh
 
Introduction to DALY and burden of disease
Introduction to DALY and burden of diseaseIntroduction to DALY and burden of disease
Introduction to DALY and burden of diseaseDr Arindam Basu
 
High impact interventions in rmnch+a(mch) for itc
High impact interventions in rmnch+a(mch) for itcHigh impact interventions in rmnch+a(mch) for itc
High impact interventions in rmnch+a(mch) for itcSudha Goel
 
Census and national health survey
Census and national health surveyCensus and national health survey
Census and national health surveyPujaKushwaha3
 
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...Sumaiya Akter Snigdha
 
Session 1 introduction of demography (as of 3-1-2017)
Session 1  introduction of demography (as of 3-1-2017)Session 1  introduction of demography (as of 3-1-2017)
Session 1 introduction of demography (as of 3-1-2017)Mmedsc Hahm
 
Critics of national health policy 1991
Critics of national health policy 1991Critics of national health policy 1991
Critics of national health policy 1991RAVIKANTAMISHRA
 
International Health Regulations
International Health RegulationsInternational Health Regulations
International Health RegulationsTanveerRehman4
 
Measuring burden of disease
Measuring burden of diseaseMeasuring burden of disease
Measuring burden of diseaseVikash Keshri
 
Universal health coverage final
Universal health coverage finalUniversal health coverage final
Universal health coverage finalSnehlata Parashar
 
Global disease burden
Global disease burdenGlobal disease burden
Global disease burdenDrZahid Khan
 
International health regulation
International health regulationInternational health regulation
International health regulationVenu Bolisetti
 
Health education and promotion in nepal
Health education and promotion in nepalHealth education and promotion in nepal
Health education and promotion in nepalAmrit Dangi
 
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)Prabesh Ghimire
 
National aids control programme
National aids control programmeNational aids control programme
National aids control programmeImmanuel Joshua
 

What's hot (20)

Review of current health service planning in Nepal from province to local level
Review of current health service planning in Nepal from province to local levelReview of current health service planning in Nepal from province to local level
Review of current health service planning in Nepal from province to local level
 
Introduction to DALY and burden of disease
Introduction to DALY and burden of diseaseIntroduction to DALY and burden of disease
Introduction to DALY and burden of disease
 
High impact interventions in rmnch+a(mch) for itc
High impact interventions in rmnch+a(mch) for itcHigh impact interventions in rmnch+a(mch) for itc
High impact interventions in rmnch+a(mch) for itc
 
Census and national health survey
Census and national health surveyCensus and national health survey
Census and national health survey
 
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...
The World Health Organization STEPwise Approach to Noncommunicable Disease Ri...
 
Session 1 introduction of demography (as of 3-1-2017)
Session 1  introduction of demography (as of 3-1-2017)Session 1  introduction of demography (as of 3-1-2017)
Session 1 introduction of demography (as of 3-1-2017)
 
Critics of national health policy 1991
Critics of national health policy 1991Critics of national health policy 1991
Critics of national health policy 1991
 
International Health Regulations
International Health RegulationsInternational Health Regulations
International Health Regulations
 
Measuring burden of disease
Measuring burden of diseaseMeasuring burden of disease
Measuring burden of disease
 
Global Burden of Disease - Pakistan Presentation
Global Burden of Disease - Pakistan PresentationGlobal Burden of Disease - Pakistan Presentation
Global Burden of Disease - Pakistan Presentation
 
Universal health coverage final
Universal health coverage finalUniversal health coverage final
Universal health coverage final
 
Global disease burden
Global disease burdenGlobal disease burden
Global disease burden
 
IPHS
IPHSIPHS
IPHS
 
International health regulation
International health regulationInternational health regulation
International health regulation
 
Health education and promotion in nepal
Health education and promotion in nepalHealth education and promotion in nepal
Health education and promotion in nepal
 
DISTRICT HEALTH ACTION PLAN
DISTRICT HEALTH ACTION PLANDISTRICT HEALTH ACTION PLAN
DISTRICT HEALTH ACTION PLAN
 
LQAS 2011
LQAS 2011LQAS 2011
LQAS 2011
 
Disease surveillance
Disease surveillanceDisease surveillance
Disease surveillance
 
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)
Organogram/ Organization Structure of Nepalese Health System (Updated- Nov 2021)
 
National aids control programme
National aids control programmeNational aids control programme
National aids control programme
 

Similar to Global disease burden assessment

Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018Monkez M Yousif
 
Hypertension Community Medicine Presentation
Hypertension Community Medicine PresentationHypertension Community Medicine Presentation
Hypertension Community Medicine PresentationAdwaithA2
 
Thyroid morbidity
Thyroid morbidityThyroid morbidity
Thyroid morbidityikramdr01
 
Epid of ncd + htn
Epid of ncd + htnEpid of ncd + htn
Epid of ncd + htnRupam Kumar
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionAbhi Manu
 
Dyslipidemias in children
Dyslipidemias in childrenDyslipidemias in children
Dyslipidemias in childrenAdhi Arya
 
Prevalence of hypertension and its associated risk factors among school age c...
Prevalence of hypertension and its associated risk factors among school age c...Prevalence of hypertension and its associated risk factors among school age c...
Prevalence of hypertension and its associated risk factors among school age c...Azad Haleem
 
Hypertension.pptx
Hypertension.pptxHypertension.pptx
Hypertension.pptxnahin10
 
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyDiabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyChing-wen Lu
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1monaaboserea
 
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson Publishers
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson PublishersHypertension in Saudi Adults with Type 2 Diabetes-Crimson Publishers
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson PublishersCrimsonPublishersIOD
 
NEW NCD GUIDELINE.pptx
NEW NCD  GUIDELINE.pptxNEW NCD  GUIDELINE.pptx
NEW NCD GUIDELINE.pptxImanuIliyas
 
Diabetes lecture
Diabetes lectureDiabetes lecture
Diabetes lectureaswhite
 
America’s Obesity Epidemic &amp; The Correlation With Adulthood Cvd
America’s Obesity Epidemic &amp; The Correlation With Adulthood CvdAmerica’s Obesity Epidemic &amp; The Correlation With Adulthood Cvd
America’s Obesity Epidemic &amp; The Correlation With Adulthood Cvdlhalleck
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable diseaseDalia El-Shafei
 

Similar to Global disease burden assessment (20)

Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018
 
Hypertension Community Medicine Presentation
Hypertension Community Medicine PresentationHypertension Community Medicine Presentation
Hypertension Community Medicine Presentation
 
Thyroid morbidity
Thyroid morbidityThyroid morbidity
Thyroid morbidity
 
Lecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in childrenLecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in children
 
Epid of ncd + htn
Epid of ncd + htnEpid of ncd + htn
Epid of ncd + htn
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertension
 
Dyslipidemias in children
Dyslipidemias in childrenDyslipidemias in children
Dyslipidemias in children
 
Dyslipidemia overview 2017
Dyslipidemia overview 2017Dyslipidemia overview 2017
Dyslipidemia overview 2017
 
Prevalence of hypertension and its associated risk factors among school age c...
Prevalence of hypertension and its associated risk factors among school age c...Prevalence of hypertension and its associated risk factors among school age c...
Prevalence of hypertension and its associated risk factors among school age c...
 
cpg prev cvd 17.pptx
cpg prev cvd 17.pptxcpg prev cvd 17.pptx
cpg prev cvd 17.pptx
 
Hypertension.pptx
Hypertension.pptxHypertension.pptx
Hypertension.pptx
 
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyDiabetes and Aging: From Treatment Goals to Pharmacologic Therapy
Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1
 
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson Publishers
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson PublishersHypertension in Saudi Adults with Type 2 Diabetes-Crimson Publishers
Hypertension in Saudi Adults with Type 2 Diabetes-Crimson Publishers
 
NEW NCD GUIDELINE.pptx
NEW NCD  GUIDELINE.pptxNEW NCD  GUIDELINE.pptx
NEW NCD GUIDELINE.pptx
 
Diabetes lecture
Diabetes lectureDiabetes lecture
Diabetes lecture
 
America’s Obesity Epidemic &amp; The Correlation With Adulthood Cvd
America’s Obesity Epidemic &amp; The Correlation With Adulthood CvdAmerica’s Obesity Epidemic &amp; The Correlation With Adulthood Cvd
America’s Obesity Epidemic &amp; The Correlation With Adulthood Cvd
 
Non communicable disease
Non communicable diseaseNon communicable disease
Non communicable disease
 
Epidemiology of the Hypertension
Epidemiology of the HypertensionEpidemiology of the Hypertension
Epidemiology of the Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 

More from Praveen Nagula

historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 

More from Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSION
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 

Recently uploaded

Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxabhijeetpadhi001
 

Recently uploaded (20)

Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptx
 

Global disease burden assessment

  • 1. Strategies for assessment of global disease burden Dr. Nagula Praveen
  • 2.  WHO was founded in 1948.  GBD study – Global Burden of Diseases study (1997)  Standardized approach to the epidemiological assessment of medical conditions and risk factors.  The main categories are  1. communicable, maternal, neonatal, and nutritional diseases  2. non- communicable diseases  3. injuries  Risk factors associated with these conditions under the main categories are  A. Environmental risks  B. Behavioural risks  C. Metabolic risks
  • 3. Dis Mod - MR • Can be used to estimate age- , sex-, and country – specific prevalence from heterogenous and often sparse data sets. • Burden associated with each condition is measured as disability – adjusted life years (DALYs)
  • 4. DALYs • Combine information regarding premature death (years of life lost, YLLs) as well as disability caused by the condition (years lived with disability, YLDs) • One DALY corresponds to one lost year of health and is calculated as YLL plus YLD. • YLDs- multiplying the estimated number of incident cases by the average duration of the disease and a disability weight factor (range 0-1 where 0 is total health and 1 is total disability)
  • 6. Introduction • In 2015, exposure to high systolic blood pressure (BP) accounted for 10.7 million deaths (33.2% of deaths attributed to all risk factors) • Nearly 212 DALYs or 20.9 % of DALYs from all risk factors. • It is a leading cause of outpatient visits and a major cause of hospitalization for stroke, chronic kidney disease, heart failure and other CVDs.
  • 7. • In adults, BP levels for defining hypertension are chosen based on their relation to cardiovascular morbidity and mortality. • In children, the definition of hypertension is arbitrarily based on the normal distribution of BP in healthy children and not on BP partition values associated with any cardiovascular morbidity and mortality.
  • 8. Hypertension • Chronic elevation of average systolic BP at 140mm Hg or higher and/or diastolic BP at 90 mmHg or higher. SBP DBP Hypertension ≥ 140 mm Hg ≥ 90 mm Hg High normal 130-139 mm Hg 85-89 mm Hg normal 120 -129 mm Hg 80-89 mm Hg ideal <120 mm Hg < 80 mm Hg Hypertension ( not for ≥ 16 years) SBP, DBP at 95 percentile for sex, age and height, when measured on atleast three separate occasions High normal BP >90 < 95 percentile Grade I 95 -99 + 5 mm Hg Grade II > 99 + 5 mm Hg
  • 9. Primary, secondary and resistant hypertension • No specific cause can be identified on physical examination and routine laboratory evaluation. • Specific etiology of hypertension idenitified • 5-10% in adults • Children and adolescentes 85% • Resistant hypertension – more than target range with patient using three medications (including diuretic)
  • 10. White coat hypertension • Average BPs in the doctors office are routinely in the hypertension range while home BP measurements or 24 hour ambulatory BP measurements show normotension. • Masked hypertension or white coat normotension • 23% for SBP , 24% for DBP • 40% in some studies • Selenta and colleagues – coined the term
  • 11. WHO STEP wise approach to surveillance • Age standardized prevalence of hypertension was 33.2%. • Prevalence is highest in Africa in the range of 30% for all adults combined • Lowest in America at 18%. • Adverse intrauterine environment and low birth weight contribute to high BP in children. • 2.6% increase in risk of high SBP in overweight children compared with non-overweight children. • Sedentary lifestyle and physical inactivity were risk factors • Boys more than girls affected.
  • 12. • Three out of four adults – family history of hypertension • Half of children – family history of hypertension • Association is even greater when both parents have hypertension. •
  • 13. • Risk of CVD doubles for each increment of 30 m mHg of SBP or 10mm Hg DBP. • 40-9 years – increment in BP is associated with two fold difference in the stroke death rate, and ischaemic heart disease and from other vascular causes. • Lower BP does not confer protection against CVD • >57% of all myocardial infarctions and nearly half of all strokes occur in persons with BP in the normal range.
  • 14. • Rapsomaniki et al • 5.2 year median follow up • Association with high systolic BP were strongest for intracerebral hemorrhage, sub arachnoid hemorrhage and stable angina • Weakest for abdominal aortic aneurysm